The role and mechanisms of cordycepin in inhibiting cancer cells.


Journal

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas
ISSN: 1414-431X
Titre abrégé: Braz J Med Biol Res
Pays: Brazil
ID NLM: 8112917

Informations de publication

Date de publication:
2024
Historique:
received: 22 02 2024
accepted: 03 07 2024
medline: 28 8 2024
pubmed: 28 8 2024
entrez: 28 8 2024
Statut: epublish

Résumé

With the escalating incidence and mortality rates of cancer, there is an ever-growing emphasis on the research of anticancer drugs. Cordycepin, the primary nucleoside antibiotic isolated from Cordyceps militaris, has emerged as a remarkable agent for cancer prevention and treatment. Functioning as a natural targeted antitumor drug, cordycepin assumes an increasingly pivotal role in cancer therapy. This review elucidates the mechanisms of cordycepin in inhibiting tumor cell proliferation, inducing apoptosis, as well as its capabilities in suppressing angiogenesis and metastasis. Moreover, the immunomodulatory effects of cordycepin in cancer treatment are explored. Additionally, the current status, challenges, and future prospects of cordycepin application in clinical trials are briefly discussed. The objective is to provide a valuable reference for the utilization of cordycepin in cancer treatment.

Identifiants

pubmed: 39194034
pii: S0100-879X2024000100305
doi: 10.1590/1414-431X2024e13889
pii:
doi:

Substances chimiques

cordycepin GZ8VF4M2J8
Deoxyadenosines 0
Antineoplastic Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13889

Auteurs

Gong Yu (G)

School of Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China.

Jiahua Peng (J)

School of Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China.

Lu Li (L)

School of Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China.

Wenbin Yu (W)

Jiangxi Key Laboratory of Bioprocess Engineering, College of Life Sciences, Jiangxi Science & Technology Normal University, Nanchang, Jiangxi, China.

Bin He (B)

Jiangxi Key Laboratory of Bioprocess Engineering, College of Life Sciences, Jiangxi Science & Technology Normal University, Nanchang, Jiangxi, China.

Bin Xie (B)

School of Chinese Medicine, Jiangxi University of Chinese Medicine, Nanchang, Jiangxi, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH